LianBio American Depositary Shares
LIAN
LIAN was delisted on the 18th of March, 2024.
36 hedge funds and large institutions have $157M invested in LianBio American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 8 closing their positions.
18% more capital invested
Capital invested by funds: $133M → $157M (+$23.8M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
10% less funds holding
Funds holding: 40 → 36 (-4)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.8M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$311K |
| 3 |
Citigroup
New York
|
+$33.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$7.86M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$298K |
| 3 |
IAM
Innovis Asset Management
Chicago,
Illinois
|
-$289K |
| 4 |
Millennium Management
New York
|
-$143K |
| 5 |
Barclays
London,
United Kingdom
|
-$138K |
LIAN Hedge Fund Activity: Q1 2023 in Review
36 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q1 2023, worth a combined $157M — up 18% from $133M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of LIAN and 4 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $8.8M. The largest seller was VR Adviser, exiting entirely with an estimated $7.86M sold.
- 36 institutional investors held LianBio American Depositary Shares (LIAN) as of Q1 2023, down from 40 in Q4 2022.
- Funds reported $157M of LianBio American Depositary Shares stock for Q1 2023, up 18% quarter-over-quarter.
- 4 funds opened new LianBio American Depositary Shares positions in Q1 2023 and 8 closed out, a net change of -4 holders.
- The largest LianBio American Depositary Shares buyer in Q1 2023 was Cormorant Asset Management, an estimated $8.8M added.
- The largest LianBio American Depositary Shares seller in Q1 2023 was VR Adviser, an estimated $7.86M sold.
Based on aggregated 13F filings for Q1 2023.